Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04002583

48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

A Prospective Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComputer assisted ambulatory electroencephalogramA portable 16 channel CAA-EEG is used to detect epileptiform abnormalities in a 48 hour ambulatory electroencephalogram (EEG)

Timeline

Start date
2020-02-19
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2019-06-28
Last updated
2026-03-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04002583. Inclusion in this directory is not an endorsement.

48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease (NCT04002583) · Clinical Trials Directory